TIDMGSK

RNS Number : 6040F

GlaxoSmithKline PLC

15 July 2019

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ========================================================================== 
 a)   Name                     Ms E Walmsley 
===  ========================  ================================================ 
 b)   Position/status          Chief Executive Officer 
===  ========================  ================================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ================================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ================================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ================================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ================================================ 
 b)   Nature of the            Increase in notional interest in Ordinary 
       transaction              Shares following the re-investment of dividends 
                                paid to shareholders on 11 July 2019 on 
                                Ordinary Shares held in the Company's Deferred 
                                Annual Bonus Plan. 
===  ========================  ================================================ 
 c)   Price(s) and               Price(s)       Volume(s) 
       volume(s)                                ---------- 
                                  GBP 16.3240    209.000 
                                                ---------- 
                                  GBP 16.3240    730.000 
                                                ---------- 
                                  GBP 16.3240    733.000 
                                                ---------- 
                                  GBP 16.3240    209.000 
                                                ---------- 
===  ========================  ================================================ 
 d)   Aggregated information 
       Aggregated volume         1881.000 
       Price 
                                 GBP 16.3240 
===  ========================  ================================================ 
 e)   Date of the transaction  2019-07-12 
===  ========================  ================================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ================================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ========================================================================= 
 a)   Name                      Mr R G Connor 
===  =========================  ============================================== 
 b)   Position/status           President, Global Vaccines 
===  =========================  ============================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  ============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================= 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  ============================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  ============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================= 
 a)   Description of             Ordinary shares of 25 pence each ('Ordinary 
       the financial              Shares') 
       instrument                 ISIN: GB0009252882 
===  =========================  ============================================== 
 b)   Nature of the             Increase in notional interest in Ordinary 
       transaction               Shares following the re-investment of 
                                 dividends paid to shareholders on 11 July 
                                 2019 on Ordinary Shares held in the Company's 
                                 Deferred Annual Bonus Plan. 
===  =========================  ============================================== 
 c)   Price(s) and                Price(s)       Volume(s) 
       volume(s)                                 ---------- 
                                   GBP 16.3240    191.000 
                                                 ---------- 
                                   GBP 16.3240    109.000 
                                                 ---------- 
                                   GBP 16.3240    155.000 
                                                 ---------- 
                                   GBP 16.3240    109.000 
                                                 ---------- 
===  =========================  ============================================== 
 d)   Aggregated information 
       Aggregated volume          564.000 
       Price 
 
                                  GBP 16.3240 
===  =========================  ============================================== 
 e)   Date of the transaction   2019-07-12 
===  =========================  ============================================== 
 f)   Place of the transaction  London Stock Exchange (XLON) 
===  =========================  ============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ========================================================================== 
 a)   Name                     Mr N Hirons 
===  ========================  ================================================ 
 b)   Position/status          SVP, Global Ethics & Compliance 
===  ========================  ================================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ================================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ================================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ================================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ================================================ 
 b)   Nature of the            Increase in notional interest in Ordinary 
       transaction              Shares following the re-investment of dividends 
                                paid to shareholders on 11 July 2019 on 
                                Ordinary Shares held in the Company's Deferred 
                                Annual Bonus Plan. 
===  ========================  ================================================ 
 c)   Price(s) and               Price(s)       Volume(s) 
       volume(s)                                ---------- 
                                  GBP 16.3240    80.000 
                                                ---------- 
                                  GBP 16.3240    68.000 
                                                ---------- 
                                  GBP 16.3240    81.000 
                                                ---------- 
                                  GBP 16.3240    68.000 
                                                ---------- 
===  ========================  ================================================ 
 d)   Aggregated information 
       Aggregated volume         297.000 
       Price 
 
                                 GBP 16.3240 
===  ========================  ================================================ 
 e)   Date of the transaction  2019-07-12 
===  ========================  ================================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ================================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ========================================================================== 
 a)   Name                     Mr L Miels 
===  ========================  ================================================ 
 b)   Position/status          President, Global Pharmaceuticals 
===  ========================  ================================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ================================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ================================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ================================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ================================================ 
 b)   Nature of the            Increase in notional interest in Ordinary 
       transaction              Shares following the re-investment of dividends 
                                paid to shareholders on 11 July 2019 on 
                                Ordinary Shares held in the Company's Deferred 
                                Annual Bonus Plan. 
===  ========================  ================================================ 
 c)   Price(s) and               Price(s)       Volume(s) 
       volume(s)                                ---------- 
                                  GBP 16.3240    203.000 
                                                ---------- 
                                  GBP 16.3240    147.000 
                                                ---------- 
===  ========================  ================================================ 
 d)   Aggregated information 
       Aggregated volume         350.000 
       Price 
 
 
                                 GBP 16.3240 
===  ========================  ================================================ 
 e)   Date of the transaction  2019-07-12 
===  ========================  ================================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ================================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ========================================================================== 
 a)   Name                     Mr D Redfern 
===  ========================  ================================================ 
 b)   Position/status          Chief Strategy Officer 
===  ========================  ================================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ================================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ================================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ================================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ================================================ 
 b)   Nature of the            Increase in notional interest in Ordinary 
       transaction              Shares following the re-investment of dividends 
                                paid to shareholders on 11 July 2019 on 
                                Ordinary Shares held in the Company's Deferred 
                                Annual Bonus Plan. 
===  ========================  ================================================ 
 c)   Price(s) and               Price(s)       Volume(s) 
       volume(s)                                ---------- 
                                  GBP 16.3240    86.000 
                                                ---------- 
                                  GBP 16.3240    181.000 
                                                ---------- 
                                  GBP 16.3240    150.000 
                                                ---------- 
                                  GBP 16.3240    86.000 
                                                ---------- 
===  ========================  ================================================ 
 d)   Aggregated information 
       Aggregated volume         503.000 
       Price 
                                 GBP 16.3240 
===  ========================  ================================================ 
 e)   Date of the transaction  2019-07-12 
===  ========================  ================================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ================================================ 
 
 
 1.   Details of PDMR/person closely associated with them ('PCA') 
     ========================================================================= 
 a)   Name                    Mr R Simard 
===  =======================  ================================================ 
 b)   Position/status         President, Pharmaceuticals Supply Chain 
===  =======================  ================================================ 
 c)   Initial notification/   Initial notification 
       amendment 
===  =======================  ================================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================= 
 a)   Name                    GlaxoSmithKline plc 
===  =======================  ================================================ 
 b)   LEI                     5493000HZTVUYLO1D793 
===  =======================  ================================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================= 
 a)   Description              Ordinary shares of 25 pence each ('Ordinary 
       of the financial         Shares') 
       instrument               ISIN: GB0009252882 
===  =======================  ================================================ 
 b)   Nature of the           Increase in notional interest in Ordinary 
       transaction             Shares following the re-investment of dividends 
                               paid to shareholders on 11 July 2019 on 
                               Ordinary Shares held in the Company's Deferred 
                               Annual Bonus Plan. 
===  =======================  ================================================ 
 c)   Price(s) and              Price(s)       Volume(s) 
       volume(s)                               ---------- 
                                 GBP 16.3240    65.000 
                                               ---------- 
===  =======================  ================================================ 
 d)   Aggregated information 
       Aggregated volume        N/A 
       Price 
===  =======================  ================================================ 
 e)   Date of the             2019-07-12 
       transaction 
===  =======================  ================================================ 
 f)   Place of the            London Stock Exchange (XLON) 
       transaction 
===  =======================  ================================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ========================================================================== 
 a)   Name                     Mr P C Thomson 
===  ========================  ================================================ 
 b)   Position/status          President, Global Affairs 
===  ========================  ================================================ 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ================================================ 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ================================================ 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ================================================ 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  ========================  ================================================ 
 b)   Nature of the            Increase in notional interest in Ordinary 
       transaction              Shares following the re-investment of dividends 
                                paid to shareholders on 11 July 2019 on 
                                Ordinary Shares held in the Company's Deferred 
                                Annual Bonus Plan. 
===  ========================  ================================================ 
 c)   Price(s) and               Price(s)       Volume(s) 
       volume(s)                                ---------- 
                                  GBP 16.3240    105.000 
                                                ---------- 
                                  GBP 16.3240    82.000 
                                                ---------- 
                                  GBP 16.3240    102.000 
                                                ---------- 
===  ========================  ================================================ 
 d)   Aggregated information 
       Aggregated volume         289.000 
       Price 
                                 GBP 16.3240 
===  ========================  ================================================ 
 e)   Date of the transaction  2019-07-12 
===  ========================  ================================================ 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  ================================================ 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================== 
 a)   Name                     Mr B McNamara 
===  ========================  ============================================== 
 b)   Position/status          CEO, GSK Consumer Healthcare 
===  ========================  ============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================== 
 a)   Description of            American Depositary Shares ('ADSs') 
       the financial             ISIN: US37733W1053 
       instrument 
===  ========================  ============================================== 
 b)   Nature of the            Increase in notional interest in ADS following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 11 July 2019 on ADS held 
                                in the Company's Deferred Annual Bonus 
                                Plan. 
===  ========================  ============================================== 
 c)   Price(s) and               Price(s)    Volume(s) 
       volume(s)                             ---------- 
                                  $ 40.9300   76.000 
                                             ---------- 
                                  $ 40.9300   78.000 
                                             ---------- 
                                  $ 40.9300   72.000 
                                             ---------- 
===  ========================  ============================================== 
 d)   Aggregated information 
       Aggregated volume         226.000 
       Price 
                                 $ 40.9300 
===  ========================  ============================================== 
 e)   Date of the transaction  2019-07-12 
===  ========================  ============================================== 
 f)   Place of the             New York Stock Exchange (XNYS) 
       transaction 
===  ========================  ============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================== 
 a)   Name                     Dr H Barron 
===  ========================  ============================================== 
 b)   Position/status           Chief Scientific Officer and President, 
                                 R&D 
===  ========================  ============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================== 
 a)   Description of            American Depositary Shares ('ADSs') 
       the financial             ISIN: US37733W1053 
       instrument 
===  ========================  ============================================== 
 b)   Nature of the            Increase in notional interest in ADS following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 11 July 2019 on ADS held 
                                in the Company's Deferred Annual Bonus 
                                Plan. 
===  ========================  ============================================== 
 c)   Price(s) and               Price(s)    Volume(s) 
       volume(s)                             ---------- 
                                  $ 40.9300   428.000 
                                             ---------- 
===  ========================  ============================================== 
 d)   Aggregated information 
       Aggregated volume         n/a 
       Price 
===  ========================  ============================================== 
 e)   Date of the transaction  2019-07-12 
===  ========================  ============================================== 
 f)   Place of the             New York Stock Exchange (XNYS) 
       transaction 
===  ========================  ============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================== 
 a)   Name                     Mr J Ford 
===  ========================  ============================================== 
 b)   Position/status          SVP and General Counsel 
===  ========================  ============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================== 
 a)   Description of            American Depositary Shares ('ADSs') 
       the financial             ISIN: US37733W1053 
       instrument 
===  ========================  ============================================== 
 b)   Nature of the            Increase in notional interest in ADS following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 11 July 2019 on ADS held 
                                in the Company's Deferred Annual Bonus 
                                Plan. 
===  ========================  ============================================== 
 c)   Price(s) and               Price(s)    Volume(s) 
       volume(s)                             ---------- 
                                  $ 40.9300   36.000 
                                             ---------- 
===  ========================  ============================================== 
 d)   Aggregated information   n/a 
       Aggregated volume 
       Price 
===  ========================  ============================================== 
 e)   Date of the transaction  2019-07-12 
===  ========================  ============================================== 
 f)   Place of the             New York Stock Exchange (XNYS) 
       transaction 
===  ========================  ============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================== 
 a)   Name                     Ms K Terrell 
===  ========================  ============================================== 
 b)   Position/status          Chief Digital & Technology Officer 
===  ========================  ============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  ============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  ============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  ============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================== 
 a)   Description of            American Depositary Shares ('ADSs') 
       the financial             ISIN: US37733W1053 
       instrument 
===  ========================  ============================================== 
 b)   Nature of the            Increase in notional interest in ADS following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 11 July 2019 on ADS held 
                                in the Company's Deferred Annual Bonus 
                                Plan. 
===  ========================  ============================================== 
 c)   Price(s) and               Price(s)    Volume(s) 
       volume(s)                             ---------- 
                                  $ 40.9300   25.000 
                                             ---------- 
                                  $ 40.9300   91.000 
                                             ---------- 
===  ========================  ============================================== 
 d)   Aggregated information 
       Aggregated volume         116.000 
       Price 
                                 $ 40.9300 
===  ========================  ============================================== 
 e)   Date of the transaction  2019-07-12 
===  ========================  ============================================== 
 f)   Place of the             New York Stock Exchange (XNYS) 
       transaction 
===  ========================  ============================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHDELFFKDFFBBV

(END) Dow Jones Newswires

July 15, 2019 13:19 ET (17:19 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Gsk Charts.
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Gsk Charts.